Breaking News

OctoPlus, Galapagos Sign Manufacturing Contract

OctoPlus N.V. has signed a pharmaceutical development contract with Galapagos N.V.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

OctoPlus N.V. has signed a pharmaceutical development contract with Galapagos N.V. OctoPlus will manufacture clinical trial material for Galapagos’ Phase II study of Nanocort, a liposome formulation of prednisolone....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters